The store will not work correctly when cookies are disabled.
4-(4-(4-methoxyphenyl)piperazin-1-yl)-2-(pyridin-2-yl)quinazoline
ID: ALA4079583
PubChem CID: 58279815
Max Phase: Preclinical
Molecular Formula: C24H23N5O
Molecular Weight: 397.48
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: COc1ccc(N2CCN(c3nc(-c4ccccn4)nc4ccccc34)CC2)cc1
Standard InChI: InChI=1S/C24H23N5O/c1-30-19-11-9-18(10-12-19)28-14-16-29(17-15-28)24-20-6-2-3-7-21(20)26-23(27-24)22-8-4-5-13-25-22/h2-13H,14-17H2,1H3
Standard InChI Key: BNLATJNUBANGFF-UHFFFAOYSA-N
Molfile:
RDKit 2D
30 34 0 0 0 0 0 0 0 0999 V2000
21.4384 -20.2794 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
22.1506 -20.6883 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.8602 -20.2789 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
22.8574 -19.4521 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.4395 -19.4557 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.1477 -19.0439 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.1457 -18.2281 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.4363 -17.8231 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.7274 -18.2357 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.7328 -19.0502 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.1522 -21.5075 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.4387 -21.9194 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
21.4381 -22.7400 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.1504 -23.1496 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.8606 -22.7368 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.8576 -21.9176 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.5673 -19.0361 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
24.2792 -19.4477 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.9870 -19.0351 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.9874 -18.2135 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
24.2738 -17.8060 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.5598 -18.2161 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.6989 -17.8001 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.4083 -18.2121 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.1193 -17.7994 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.1190 -16.9772 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.4018 -16.5695 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.6937 -16.9804 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.8299 -16.5670 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
28.5385 -16.9740 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5 1 2 0
1 2 1 0
2 3 2 0
3 4 1 0
4 6 2 0
5 6 1 0
6 7 1 0
7 8 2 0
8 9 1 0
9 10 2 0
10 5 1 0
11 12 2 0
12 13 1 0
13 14 2 0
14 15 1 0
15 16 2 0
16 11 1 0
2 11 1 0
4 17 1 0
17 18 1 0
17 22 1 0
18 19 1 0
19 20 1 0
20 21 1 0
21 22 1 0
20 23 1 0
23 24 2 0
24 25 1 0
25 26 2 0
26 27 1 0
27 28 2 0
28 23 1 0
26 29 1 0
29 30 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 397.48 | Molecular Weight (Monoisotopic): 397.1903 | AlogP: 4.03 | #Rotatable Bonds: 4 |
Polar Surface Area: 54.38 | Molecular Species: NEUTRAL | HBA: 6 | HBD: ┄ |
#RO5 Violations: ┄ | HBA (Lipinski): 6 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 3.96 | CX LogP: 5.40 | CX LogD: 5.40 |
Aromatic Rings: 4 | Heavy Atoms: 30 | QED Weighted: 0.52 | Np Likeness Score: -1.49 |
References
1. White KN, Tenney K, Crews P.. (2017) The Bengamides: A Mini-Review of Natural Sources, Analogues, Biological Properties, Biosynthetic Origins, and Future Prospects., 80 (3): [PMID:28185457] [10.1021/acs.jnatprod.6b00970] |